Neuroanesthesiology update 2010

Journal of Neurosurgical Anesthesiology

Volumn 23, Issue 2, 2011, Pages 67-99

  Pasternak, Jeffrey J ^a   Lanier, William L ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

carotid endarterectomy; Craniotomy; intracranial hemorrhage; neuroprotection; spine surgery; subarachnoid hemorrhage; traumatic brain injury

Indexed keywords

ADENOSINE; AMIODARONE; ANESTHETIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; BUPIVACAINE; CLEVIDIPINE; DEXMEDETOMIDINE; DIAZEPAM; DICLOFENAC; DIPHENHYDRAMINE; DIPYRONE; ESMOLOL; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOFLURANE; KETAMINE; MILRINONE; MORPHINE; NICARDIPINE; PARACETAMOL; PHENYLEPHRINE; PIRITRAMIDE; PROPOFOL; REACTIVE OXYGEN METABOLITE; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; UNINDEXED DRUG;

ACCREDITATION; ACROMEGALY; ANESTHESIA; ANESTHESIOLOGY; BETA ADRENERGIC RECEPTOR BLOCKING; BRAIN ELECTROPHYSIOLOGY; BRAIN HEMORRHAGE; CAROTID ARTERY DISEASE; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; NEUROIMAGING; NEUROPROTECTION; NEUROSURGERY; NEUROTOXICITY; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION CONTROL; REVIEW; SPINAL CORD INJURY; SPINE SURGERY; TRANSCUTANEOUS NERVE STIMULATION; TRAUMATIC BRAIN INJURY;

ACCREDITATION; ANESTHESIA; ANESTHESIOLOGY; ANESTHETICS; ANIMALS; BRAIN INJURIES; CAROTID ARTERY DISEASES; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; INTRACRANIAL HEMORRHAGES; MONITORING, INTRAOPERATIVE; NEUROPROTECTIVE AGENTS; NEUROSURGERY; NEUROSURGICAL PROCEDURES; NEUROTOXICITY SYNDROMES; SPINAL CORD INJURIES; SPINE; SUBARACHNOID HEMORRHAGE;

EID: 79952934391     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e318210f594     Document Type: Review

References (261)

1. Hargett MJ, Beckman JD, Liguori GA, et al. Guidelines for regional anesthesia fellowship training. Reg Anesth Pain Med. 2005;30:218-225. (Pubitemid 40718902)
2. Lam AM. SNACC should develop neuroanesthesia practice guidelines: the specialty needs it, the patient deserves it, and the third party will soon demand it. J Neurosurg Anesthesiol. 2003;15:334-336. (Pubitemid 37210922)
3. Crosby G. Neuroanesthesia practice standards: we need data, not dogma. J Neurosurg Anesthesiol. 2003;15:337-340. (Pubitemid 37210923)
4. Albin M. Mission (not yet) accomplished! SNACC Newsletter. 2008;36:1-3.
5. Kofke A. The UCNS pathway-something for now! SNACC Newsletter. 2008;36:3-4.
6. Mashour GA, Lauer K, Greenfield ML, et al. Accreditation and standardization of neuroanesthesia fellowship programs: results of a specialty-wide survey. J Neurosurg Anesthesiol. 2010;22:252-255.
7. Hughey AB, Lesniak MS, Ansari SA, et al. What will anesthesiologists be anesthetizing? trends in neurosurgical procedure usage. Anesth Analg. 2010;110:1686-1697.
8. Healthcare Cost and Utilization Project-Nationwide Inpatient Sample. Rockville, MD. Available at: http://www.hcup-us.ahrq. gov. Accessed July, 2009.
9. Horner MJ, Ries L A G, Krapcho M, et al, eds. SEER Cancer Statistics Review 1975-2006. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975- 2006. Accessed July, 2009.
10. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9:581-591.
11. Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997;26:353-357. (Pubitemid 27448379)
12. Hagell P. Self-reported health in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry. 2007;78:442. (Pubitemid 46662885)
13. Hagell P, Nygren C. The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry. 2007;78:1191-1198. (Pubitemid 350057280)
14. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010;362:2077-2091.
15. Samsoon GL, Young JR. Difficult tracheal intubation: a retrospective study. Anaesthesia. 1987;42:487-490. (Pubitemid 17074035)
16. Schmitt H, Buchfelder M, Radespiel-Troger M, et al. Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology. 2000;93:110-114. (Pubitemid 30436684)
17. Khan ZH, Kashfi A, Ebrahimkhani E. A comparison of the upper lip bite test (a simple new technique) with modified Mallampati classification in predicting difficulty in endotracheal intubation: a prospective blinded study. Anesth Analg. 2003;96:595-599. (Pubitemid 36125788)
18. Sharma D, Prabhakar H, Bithal PK, et al. Predicting difficult laryngoscopy in acromegaly: a comparison of upper lip bite test with modified Mallampati classification. J Neurosurg Anesthesiol. 2010;22:138-143.
19. Schroeder HW, Oertel J, Gaab MR. Endoscopic treatment of cerebrospinal fluid pathway obstructions. Neurosurgery. 2008;62:1084-1092.
20. Baykan N, Isbir O, Gercek A, et al. Ten years of experience with pediatric neuroendoscopic third ventriculostomy: features and perioperative complications of 210 cases. J Neurosurg Anesthesiol. 2005;17:33-37. (Pubitemid 40070584)
21. Fabregas N, Valero R, Carrero E, et al. Episodic high irrigation pressure during surgical neuroendoscopy may cause intermittent intracranial circulatory insufficiency. J Neurosurg Anesthesiol. 2001;13:152-157. (Pubitemid 32244993)
22. Kalmar AF, Van Aken J, Caemaert J, et al. Value of Cushing reflex as warning sign for brain ischaemia during neuroendoscopy. Br J Anaesth. 2005;94:791-799. (Pubitemid 40753996)
23. Salvador L, Valero R, Carazo J, et al. Pressure inside the neuroendoscope: correlation with epidural intracranial pressure during neuroendoscopic procedures. J Neurosurg Anesthesiol. 2010;22:240-246.
24. Cullen DJ, Kirby RR. Beach chair position may decrease cerebral perfusion-catastrophic outcomes have occurred. APSF Newsletter. 2007;22:25-27.
25. Cullen DJ, Kirby RR. Hazards of beach chair position explored. APSF Newsletter. 2007;22:81.
26. Drummond JC, Hargens AR, Patel PM. Hydrostatic gradient is importantFblood pressure should be corrected. APSF Newsletter. 2009;24:6.
27. Munis JR. The problems of posture, pressure, and perfusion. APSF Newsletter. 2007;22:82-83.
28. Pohl A, Cullen DJ. Cerebral ischemia during shoulder surgery in the upright position: a case series. J Clin Anesth. 2005;17:463-469. (Pubitemid 41317994)
29. Murphy GS, Szokol JW, Marymont JH, et al. Cerebral oxygen desaturation events assessed by near-infrared spectroscopy during shoulder arthroscopy in the beach chair and lateral decubitus positions. Anesth Analg. 2010;111:496-505.
30. Sloan T. The incidence, volume, absorption, and timing of supratentorial pneumocephalus during posterior fossa neurosurgery conducted in the sitting position. J Neurosurg Anesthesiol. 2010;22:59-66.
31. Drummond JC. Tension pneumocephalus and intermittent drainage of ventricular CSF. Anesthesiology. 1984;60:609-610.
32. Grundy BL, Spetzler RF. Subdural pneumocephalus resulting from drainage of cerebrospinal fluid during craniotomy. Anesthesiology. 1980;52:269-271. (Pubitemid 10176870)
33. Palvolgyi R. Regional cerebral blood flow in patients with intracranial tumors. J Neurosurg. 1969;31:149-163.
34. Schmieder K, Schregel W, Harders A, et al. Dynamic cerebral autoregulation in patients undergoing surgery for intracranial tumors. Eur J Ultrasound. 2000;12:1-7.
35. Sharma D, Bithal PK, Dash HH, et al. Cerebral autoregulation and CO2 reactivity before and after elective supratentorial tumor resection. J Neurosurg Anesthesiol. 2010;22:132-137.
36. Bowie RA, Mahajan RP. Effect of magnitude of the decrease in middle cerebral artery flow velocity during the hyperaemic response test on calculated indices of autoregulation. Br J Anaesth. 1999;83:187.
37. 2 reactivity in arteriovenous malformations of the brain: a transcranial Doppler ultrasound study. J Neurosurg. 1994;80:624-630. (Pubitemid 24100281)
38. Klein KU, Schramm P, Glaser M, et al. Intraoperative monitoring of cerebral microcirculation and oxygenationFa feasibility study using a novel photo-spectrometric laser-Doppler flowmetry. J Neurosurg Anesthesiol. 2010;22:38-45.
39. Luostarinen T, Dilmen OK, Niiya T, et al. Effect of arterial blood pressure on the arterial to end-tidal carbon dioxide difference during anesthesia induction in patients scheduled for craniotomy. J Neurosurg Anesthesiol. 2010;22:303-308.
40. Buettner M, Schummer W, Huettemann E, et al. Influence of systolic-pressure-variation-guided intraoperative fluid management on organ function and oxygen transport. Br J Anaesth. 2008;101:194-199. (Pubitemid 351989656)
41. Lopes MR, Oliveira MA, Pereira VO, et al. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care. 2007;11:100.
42. Michard F, Boussat S, Chemla D, et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med. 2000;162:134-138. (Pubitemid 30469810)
43. Qiao H, Zhang J, Liang WM. Validity of pulse pressure and systolic blood pressure variation data obtained from a Datex Ohmeda S/5 monitor for predicting fluid responsiveness during surgery. J Neurosurg Anesthesiol. 2010;22:316-322.
44. Sakuma J, Suzuki K, Sasaki T, et al. Monitoring and preventing blood flow insufficiency due to clip rotation after the treatment of internal carotid artery aneurysms. J Neurosurg. 2004;100:960-962. (Pubitemid 38533982)
45. Suzuki K, Kodama N, Sasaki T, et al. Intraoperative monitoring of blood flow insufficiency in the anterior choroidal artery during aneurysm surgery. J Neurosurg. 2003;98:507-514. (Pubitemid 36262770)
46. Szelenyi A, Langer D, Beck J, et al. Transcranial and direct cortical stimulation for motor evoked potential monitoring in intracerebral aneurysm surgery. Neurophysiol Clin. 2007;37:391-398. (Pubitemid 350236870)
47. Szelenyi A, Langer D, Kothbauer K, et al. Monitoring of muscle motor evoked potentials during cerebral aneurysm surgery: intraoperative changes and postoperative outcome. J Neurosurg. 2006;105:675-681. (Pubitemid 44703928)
48. Irie T, Yoshitani K, Ohnishi Y, et al. The efficacy of motor-evoked potentials on cerebral aneurysm surgery and new-onset postoperative motor deficits. J Neurosurg Anesthesiol. 2010;22:247-251.
49. Kakimoto M, Kawaguchi M, Yamamoto Y, et al. Tetanic stimulation of the peripheral nerve before transcranial electrical stimulation can enlarge amplitudes of myogenic motor evoked potentials during general anesthesia with neuromuscular blockade. Anesthesiology. 2005;102:733-738. (Pubitemid 40462852)
50. Cupido CM, Hicks AL, Martin J. Neuromuscular fatigue during repetitive stimulation in elderly and young adults. Eur J Appl Physiol Occup Physiol. 1992;65:567-672.
51. Yamamoto Y, Kawaguchi M, Hayashi H, et al. Evaluation of posttetanic motor evoked potentialsFthe influences of repetitive use, the residual effects of tetanic stimulation to peripheral nerve, and the variability. J Neurosurg Anesthesiol. 2010;22:6-10.
52. Duffau H, Lopes M, Arthuis F, et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-1996) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005;76:845-851. (Pubitemid 40805817)
53. Conte V, Magni L, Songa V, et al. Analysis of propofol/remifentanil infusion protocol for tumor surgery with intraoperative brain mapping. J Neurosurg Anesthesiol. 2010;22:119-127.
54. Bekker A, Sturaitis MK. Dexmedetomidine for neurological surgery. Neurosurgery. 2005;57:1-10.
55. Karlsson BR, Forsman M, Roald OK, et al. Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg. 1990;71:125-129.
56. Zornow MH, Fleischer JE, Scheller MS, et al. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane- anesthetized dog. Anesth Analg. 1990;70:624-630. (Pubitemid 20384196)
57. Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002;95:1052-1059.
58. Zornow MH, Maze M, Dyck JB, et al. Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab. 1993;13:350-353. (Pubitemid 23067473)
59. Drummond JC, Dao AV, Roth DM, et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology. 2008;108:225-232. (Pubitemid 351156732)
60. Drummond JC, Sturaitis MK. Brain tissue oxygenation during dexmedetomidine administration in surgical patients with neurovascular injuries. J Neurosurg Anesthesiol. 2010;22:336-341.
61. Rohra DK, Saito SY, Ohizumi Y. Strain-specific effects of acidic pH on contractile state of aortas from Wistar and Wistar Kyoto rats. Eur J Pharmacol. 2003;476:123-130. (Pubitemid 37315544)
62. Schwartz AE, Adams DC. Hypocapnia enhances the pressor effect of phenylephrine during isoflurane anesthesia in monkeys. J Neurosurg Anesthesiol. 2010;22:155-157.
63. Grover AK, Crankshaw J, Triggle CR, et al. Nature of norepinephrine- sensitive Ca-pool in rabbit aortic smooth muscle: effect of pH. Life Sci. 1983;32:1553-1558. (Pubitemid 13117321)
64. Bekker A, Sturaitis M, Bloom M, et al. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg. 2008;107:1340-1347.
65. Bilotta F, Lam AM, Doronzio A, et al. Esmolol blunts postoperative hemodynamic changes after propofol-remifentanil total intravenous fast-track neuroanesthesia for intracranial surgery. J Clin Anesth. 2008;20:426-430.
66. Muzzi DA, Black S, Losasso TJ, et al. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg. 1990;70:68-71. (Pubitemid 20039981)
67. Bekker A, Didehvar S, Kim S, et al. Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience. J Neurosurg Anesthesiol. 2010;22:330-335.
68. Mordhorst C, Latz B, Kerz T, et al. Prospective assessment of postoperative pain after craniotomy. J Neurosurg Anesthesiol. 2010;22:202-206.
69. Osborn I, Sebeo J. "Scalp block" during craniotomy: a classic technique revisited. J Neurosurg Anesthesiol. 2010;22:187-194.
70. Bilotta F, Rosa G. Glucose management in the neurosurgical patient: are we yet any closer? Curr Opin Anaesthesiol. 2010;23:539-543.
71. Pasternak JJ, Lanier WL. Is nitrous oxide use appropriate in neurosurgical and neurologically at-risk patients? Curr Opin Anaesthesiol. 2010;23:544-550.
72. Flexman AM, Ng JL, Gelb AW. Acute and chronic pain following craniotomy. Curr Opin Anaesthesiol. 2010;23:551-557.
73. Niemi T, Armstrong E. Thromboprophylactic management in the neurosurgical patient with high risk for both thrombosis and intracranial bleeding. Curr Opin Anaesthesiol. 2010;23:558-563.
74. Klimek M, Dammers R. Antiepileptic drug therapy in the perioperative course of neurosurgical patients. Curr Opin Anaesthesiol. 2010;23:564-567.
75. Fabregas N, Craen RA. Anaesthesia for endoscopic neurosurgical procedures. Curr Opin Anaesthesiol. 2010;23:568-575.
76. Highton D, Elwell C, Smith M. Noninvasive cerebral oximetry: is there light at the end of the tunnel? Curr Opin Anaesthesiol. 2010;23:576-581.
77. Goepfert CE, Ifune C, Tempelhoff R. Ischemic optic neuropathy: are we any further? Curr Opin Anaesthesiol. 2010;23:582-587.
78. Anderson SW, Todd MM, Hindman BJ, et al. Effects of intraoperative hypothermia on neuropsychological outcomes after intracranial aneurysm surgery. Ann Neurol. 2006;60:518-527. (Pubitemid 44871794)
79. Todd MM, Hindman BJ, Clarke WR, et al. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135-145. (Pubitemid 40096610)
80. Ferch R, Pasqualin A, Pinna G, et al. Temporary arterial occlusion in the repair of ruptured intracranial aneurysms: an analysis of risk factors for stroke. J Neurosurg. 2002;97:836-842. (Pubitemid 35222405)
81. Ogilvy CS, Carter BS, Kaplan S, et al. Temporary vessel occlusion for aneurysm surgery: risk factors for stroke in patients protected by induced hypothermia and hypertension and intravenous mannitol administration. J Neurosurg. 1996;84:785-791. (Pubitemid 26120093)
82. Samson D, Batjer HH, Bowman G, et al. A clinical study of the parameters and effects of temporary arterial occlusion in the management of intracranial aneurysms. Neurosurgery. 1994;34:22-28.
83. Lavine SD, Masri LS, Levy ML, et al. Temporary occlusion of the middle cerebral artery in intracranial aneurysm surgery: time limitation and advantage of brain protection. J Neurosurg. 1997;87:817-824.
84. Hindman BJ, Bayman EO, Pfisterer WK, et al. No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the intraoperative hypothermia for aneurysm surgery trial. Anesthesiology. 2010;112:86-101.
85. de Oliveira JG, Beck J, Ulrich C, et al. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev. 2007;30:22-30. (Pubitemid 44900231)
86. Hoh BL, Topcuoglu MA, Singhal AB, et al. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55:779-786.
87. Hohlrieder M, Spiegel M, Hinterhoelzl J, et al. Cerebral vasospasm and ischaemic infarction in clipped and coiled intracranial aneurysm patients. Eur J Neurol. 2002;9:389-399. (Pubitemid 35013895)
88. Natarajan SK, Sekhar LN, Ghodke B, et al. Outcomes of ruptured intracranial aneurysms treated by microsurgical clipping and endovascular coiling in a high-volume center. AJNR Am J Neuroradiol. 2008;29:753-759. (Pubitemid 351571561)
89. Dumont AS, Crowley RW, Monteith SJ, et al. Endovascular treatment or neurosurgical clipping of ruptured intracranial aneurysms: effect on angiographic vasospasm, delayed ischemic neurological deficit, cerebral infarction, and clinical outcome. Stroke. 2010;41:2519-2524.
90. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, doubleblind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015-3021.
91. Giller CA, Wills MJ, Giller AM, et al. Distribution of hematocrit values after aneurysmal subarachnoid hemorrhage. J Neuroimaging. 1998;8:169-170. (Pubitemid 28311660)
92. Diedler J, Sykora M, Hahn P, et al. Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage. Crit Care. 2010;14: R63.
93. Sampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care. 2010;12:4-9.
94. Kurtz P, Schmidt JM, Claassen J, et al. Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit Care. 2010;13:10-16.
95. Levine J, Kofke A, Cen L, et al. Red blood cell transfusion is associated with infection and extracerebral complications after subarachnoid hemorrhage. Neurosurgery. 2010;66:312-318.
96. Naidech AM, Shaibani A, Garg RK, et al. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care. 2010;13:313-320.
97. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862-866. (Pubitemid 40911459)
98. Lanier WL, Stangland KJ, Scheithauer BW, et al. The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: examination of a model. Anesthesiology. 1987;66:39-48. (Pubitemid 17218025)
99. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996;71:801-812.
100. Weir CJ, Murray GD, Dyker AG, et al. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? results of a long-term follow up study. BMJ. 1997;314:1303-1306. (Pubitemid 27183316)
101. Bilotta F, Caramia R, Paoloni FP, et al. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology. 2009;110:611-619.
102. Thiele RH, Pouratian N, Zuo Z, et al. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology. 2009;110:603-610.
103. Oddo M, Schmidt JM, Carrera E, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med. 2008;36:3233-3238.
104. Helbok R, Schmidt JM, Kurtz P, et al. Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care. 2010;12:317-323.
105. Naidech AM, Levasseur K, Liebling S, et al. Moderate Hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care. 2010;12:181-187.
106. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery. 2000;47:602-606.
107. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci. 2002;9:279-281.
108. Muroi C, Terzic A, Fortunati M, et al. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69:33-39. (Pubitemid 350181007)
109. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011-1015. (Pubitemid 40629294)
110. Wong GK, Chan MT, Boet R, et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol. 2006;18:142-148. (Pubitemid 44510114)
111. Dorhout Mees SM, Bertens D, van der Worp HB, et al. Magnesium and headache after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2010;81:490-493.
112. Dorhout Mees SM, van den Bergh WM, Algra A, et al. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2007;78:729-731. (Pubitemid 46998844)
113. Wong GK, Poon WS, Chan MT, et al. Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial. Stroke. 2010;41:1841-1844.
114. Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med. 2010;38:1284-1290.
115. Wong GK, Poon WS, Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921-926.
116. Ma L, Liu WG, Zhang JM, et al. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials. Brain Inj. 2010;24:730-735.
117. Prevedello DM, Cordeiro JG, de Morais AL, et al. Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surg Neurol. 2006;65(suppl 1):14-20.
118. van Norden AG, van den Bergh WM, Rinkel GJ. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther. 2005;30:439-442. (Pubitemid 41603017)
119. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;96:510-514. (Pubitemid 34230205)
120. Kramer AH, Fletcher JJ. Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2010;12:285-296.
121. Avitsian R, Fiorella D, Soliman MM, et al. Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series. J Neurosurg Anesthesiol. 2007;19:125-129. (Pubitemid 46596681)
122. Schmidt U, Bittner E, Pivi S, et al. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone. Anesth Analg. 2010;110:895-902.
123. Caner H, Oruckaptan H, Bolay H, et al. The role of lipid peroxidation in the genesis of vasospasm secondary to subarachnoid hemorrhage. Kobe J Med Sci. 1991;37:13-20.
124. Takasago T, Peters EE, Graham DI, et al. Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br J Pharmacol. 1997;122:1251-1256. (Pubitemid 27494244)
125. Battin EE, Brumaghim JL. Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys. 2009;55:1-23.
126. Kocaogullar Y, Ilik K, Esen H, et al. Preventive effects of intraperitoneal selenium on cerebral vasospasm in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2010;22:53-58.
127. Spallone A, Pastore FS. Cerebral vasospasm in a double-injection model in rabbit. Surg Neurol. 1989;32:408-417. (Pubitemid 20030856)
128. Yang G, Zhou R. Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J Trace Elem Electrolytes Health Dis. 1994;8:159-165.
129. Groff MW, Adams DC, Kahn RA, et al. Adenosine-induced transient asystole for management of a basilar artery aneurysm: case report. J Neurosurg. 1999;91:687-690. (Pubitemid 30133470)
130. Hashimoto T, Young WL, Aagaard BD, et al. Adenosine-induced ventricular asystole to induce transient profound systemic hypotension in patients undergoing endovascular therapy: doseresponse characteristics. Anesthesiology. 2000;93:998-1001.
131. Heppner PA, Ellegala DB, Robertson N, et al. Basilar tip aneurysm-adenosine induced asystole for the treatment of a basilar tip aneurysm following failure of temporary clipping. Acta Neurochir (Wien). 2007;149:517-520. (Pubitemid 46669375)
132. Owall A, Gordon E, Lagerkranser M, et al. Clinical experience with adenosine for controlled hypotension during cerebral aneurysm surgery. Anesth Analg. 1987;66:229-234. (Pubitemid 17029166)
133. Luostarinen T, Takala RS, Niemi TT, et al. Adenosine-induced cardiac arrest during intraoperative cerebral aneurysm rupture. World Neurosurg. 2010;73:79-83.
134. Bebawy JF, Gupta DK, Bendok BR, et al. Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: doseresponse data and safety profile. Anesth Analg. 2010;110:1406-1411.
135. Powers CJ, Wright DR, McDonagh DL, et al. Transient adenosine-induced asystole during the surgical treatment of anterior circulation cerebral aneurysms: technical note. Neurosurgery. 2010;67:461-470.
136. Halliday A, Harrison M, Hayter E, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376:1074-1084.
137. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST). Lancet. 1998;351:1379-1387.
138. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med. 1998;339:1415-1425. (Pubitemid 28516064)
139. Perkins WJ, Lanzino G, Brott TG. Carotid stenting versus endarterectomy: new results in perspective. Mayo Clin Proc. 2010;85:1101-1108.
140. Adams HP Jr. Management of carotid artery stenosis: endarterectomy or stenting? Mayo Clin Proc. 2010;85:1071-1072.
141. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-1737.
142. Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the stentprotected angioplasty versus carotid endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7:893-902.
143. Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358:1572-1579. (Pubitemid 351519817)
144. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660-1671. (Pubitemid 44583956)
145. McCabe DJ, Pereira AC, Clifton A, et al. Restenosis after carotid angioplasty, stenting, or endarterectomy in the carotid and vertebral artery transluminal angioplasty study (CAVATAS). Stroke. 2005;36:281-286. (Pubitemid 40170809)
146. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
147. Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
148. Mantese VA, Timaran CH, Chiu D, et al. The carotid revascularization endarterectomy versus stenting trial (CREST): stenting versus carotid endarterectomy for carotid disease. Stroke. 2010;41: S31-S34.
149. Bonati LH, Dobson J, Algra A, et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet. 2010;376:1062-1073.
150. Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375:985-997.
151. Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the international carotid stenting study (ICSS). Lancet Neurol. 2010;9:353-362.
152. Young KC, Holloway RG, Burgin WS, et al. A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. J Stroke Cerebrovasc Dis. 2010;19:404-409.
153. Macdonald S, Evans DH, Griffiths PD, et al. Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis. 2010;29:282-289.
154. Fan L, Evans DH. A real-time and fine resolution analyser used to estimate the instantaneous energy distribution of Doppler signals. Ultrasound Med Biol. 1994;20:445-462.
155. Smith JL, Evans DH, Fan L, et al. Interpretation of embolic phenomena during carotid endarterectomy. Stroke. 1995;26:2281-2284.
156. Halsey JH Jr. Risks and benefits of shunting in carotid endarterectomy: the international transcranial Doppler collaborators. Stroke. 1992;23:1583-1587.
157. Cao P, Giordano G, Zannetti S, et al. Transcranial Doppler monitoring during carotid endarterectomy: is it appropriate for selecting patients in need of a shunt? J Vasc Surg. 1997;26:973-979.
158. Mazul-Sunko B, Hromatko I, Tadinac M, et al. Subclinical neurocognitive dysfunction after carotid endarterectomy-the impact of shunting. J Neurosurg Anesthesiol. 2010;22:195-201.
159. Moritz S, Schmidt C, Bucher M, et al. Neuromonitoring in carotid surgery: are the results obtained in awake patients transferable to patients under sevoflurane/fentanyl anesthesia? J Neurosurg Anesthesiol. 2010;22:288-295.
160. Shakespeare WA, Lanier WL, Perkins WJ, et al. Airway management in patients who develop neck hematomas after carotid endarterectomy. Anesth Analg. 2010;110:588-593.
161. Erickson KM, Cole DJ. Carotid artery disease: stenting versus endarterectomy. Br J Anaesth. 2010;105(suppl 1):34-49.
162. Deyo RA, Mirza SK, Martin BI, et al. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA. 2010;303:1259-1265.
163. Jung A, Schramm J. How to reduce recurrent laryngeal nerve palsy in anterior cervical spine surgery: a prospective observational study. Neurosurgery. 2010;67:10-15.
164. Jung A, Schramm J, Lehnerdt K, et al. Recurrent laryngeal nerve palsy during anterior cervical spine surgery: a prospective study. J Neurosurg Spine. 2005;2:123-127.
165. Shribman AJ, Smith G, Achola KJ. Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth. 1987;59:295-299. (Pubitemid 17025602)
166. Yoo KY, Jeong CW, Kim SJ, et al. Altered cardiovascular responses to tracheal intubation in patients with complete spinal cord injury: relation to time course and affected level. Br J Anaesth. 2010;105:753-759.
167. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol. 2010;6:363-372.
168. Osada T, Watanabe M, Hasuo A, et al. Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice. J Neurosurg Spine. 2010;13:516-523.
169. Wright LS, Prowse KR, Wallace K, et al. Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp Cell Res. 2006;312:2107-2120. (Pubitemid 43850935)
170. Hu SL, Luo HS, Li JT, et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells. Crit Care Med. 2010;38:2181-2189.
171. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med. 2002;27:481-486.
172. Pandey CK, Bose N, Garg G, et al. Gabapentin for the treatment of pain in guillain-barre syndrome: a double-blinded, placebocontrolled, crossover study. Anesth Analg. 2002;95:1719-1723. (Pubitemid 35423969)
173. Pandey CK, Priye S, Singh S, et al. Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy. Can J Anaesth. 2004;51:358-363. (Pubitemid 38701945)
174. Pandey CK, Singhal V, Kumar M, et al. Gabapentin provides effective postoperative analgesia whether administered pre-emptively or post-incision. Can J Anaesth. 2005;52:827-831. (Pubitemid 41723657)
175. Pandey CK, Navkar DV, Giri PJ, et al. Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: a randomized, double-blind, placebo-controlled study. J Neurosurg Anesthesiol. 2005;17:65-68. (Pubitemid 40602752)
176. Rusy LM, Hainsworth KR, Nelson TJ, et al. Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial. Anesth Analg. 2010;110:1393-1398.
177. Carstensen M, Moller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anaesth. 2010;104:401-406.
178. Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg. 2004;99:482-495. (Pubitemid 38970424)
179. Loftus RW, Yeager MP, Clark JA, et al. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010;113:639-646.
180. Amr YM. Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial. Pain Physician. 2010;13:245-249.
181. Elder JB, Hoh DJ, Liu CY, et al. Postoperative continuous paravertebral anesthetic infusion for pain control in posterior cervical spine surgery: a case-control study. Neurosurgery. 2010;66:99-106.
182. Han JS, Chen XH, Sun SL, et al. Effect of low-and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain. 1991;47:295-298.
183. Breit R, Van der Wall H. Transcutaneous electrical nerve stimulation for postoperative pain relief after total knee arthroplasty. J Arthroplasty. 2004;19:45-48. (Pubitemid 38112332)
184. Hamza MA, White PF, Ahmed HE, et al. Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology. 1999;91:1232-1238. (Pubitemid 29506083)
185. Likar R, Molnar M, Pipam W, et al. Postoperative transcutaneous electrical nerve stimulation (TENS) in shoulder surgery (randomized, double blind, placebo controlled pilot trial). Schmerz. 2001;15:158-163. (Pubitemid 32625042)
186. Unterrainer AF, Friedrich C, Krenn MH, et al. Postoperative and preincisional electrical nerve stimulation TENS reduce postoperative opioid requirement after major spinal surgery. J Neurosurg Anesthesiol. 2010;22:1-5.
187. Juul N, Morris GF, Marshall SB, et al. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg. 2000;92:1-6. (Pubitemid 30022080)
188. Murray GD, Butcher I, McHugh GS, et al. Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24:329-337. (Pubitemid 46492154)
189. Bremmer R, de Jong BM, Wagemakers M, et al. The course of intracranial pressure in traumatic brain injury: relation with outcome and CT-characteristics. Neurocrit Care. 2010;12:362-368.
190. Biswas AK, Summerauer JF. Heart rate variability and brain death. J Neurosurg Anesthesiol. 2004;16:62. (Pubitemid 38057400)
191. Conci F, Di Rienzo M, Castiglioni P. Blood pressure and heart rate variability and baroreflex sensitivity before and after brain death. J Neurol Neurosurg Psychiatry. 2001;71:621-631. (Pubitemid 33010577)
192. Hon EH, Lee ST. Electronic evaluation of the fetal heart rate: patterns preceding fetal death, further observations. Am J Obstet Gynecol. 1963;87:814-826.
193. Kleiger RE, Miller JP, Bigger JT Jr, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262. (Pubitemid 17036947)
194. Mowery NT, Norris PR, Riordan W, et al. Cardiac uncoupling and heart rate variability are associated with intracranial hypertension and mortality: a study of 145 trauma patients with continuous monitoring. J Trauma. 2008;65:621-627.
195. Kahraman S, Dutton RP, Hu P, et al. Heart rate and pulse pressure variability are associated with intractable intracranial hypertension after severe traumatic brain injury. J Neurosurg Anesthesiol. 2010;22:296-302.
196. Kerwin AJ, Schinco MA, Tepas JJ III, et al. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67:277-282.
197. Oddo M, Levine JM, Frangos S, et al. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry. 2009;80:916-920.
198. White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006;102:1836-1846. (Pubitemid 43799864)
199. Hansen PB, Jensen BL, Skott O. Chloride regulates afferent arteriolar contraction in response to depolarization. Hypertension. 1998;32:1066-1070. (Pubitemid 29001438)
200. Qureshi AI, Suarez JI, Bhardwaj A, et al. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26:440-446. (Pubitemid 28141476)
201. Schwarz S, Georgiadis D, Aschoff A, et al. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136-140. (Pubitemid 34055759)
202. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726-735. (Pubitemid 13160821)
203. Bourdeaux C, Brown J. Sodium bicarbonate lowers intracranial pressure after traumatic brain injury. Neurocrit Care. 2010;13:24-28.
204. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury part I: an evidence-based review of nonpharmacological interventions. Brain Inj. 2010;24:694-705.
205. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions. Brain Inj. 2010;24:706-721.
206. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury Part III: an evidence-based review of interventions used to promote arousal from coma. Brain Inj. 2010;24:722-729.
207. Teig M, Smith M. Where should patients with severe traumatic brain injury be managed? all patient should be managed in a neurocritical care unit. J Neurosurg Anesthesiol. 2010;22:357-359.
208. Petsas A, Waldmann C. Where should patients with severe traumatic brain injury be managed? patients can be safely managed in a nonspecialist center. J Neurosurg Anesthesiol. 2010;22:354-356.
209. Mantz J, Degos V, Laigle C. Recent advances in pharmacologic neuroprotection. Eur J Anaesthesiol. 2010;27:6-10.
210. Blaylock M, Engelhardt T, Bissonnette B. Fundamentals of neuronal apoptosis relevant to pediatric anesthesia. Paediatr Anaesth. 2010;20:383-395.
211. Creeley CE, Olney JW. The young: neuroapoptosis induced by anesthetics and what to do about it. Anesth Analg. 2010;110:442-448.
212. Tang J, Eckenhoff MF, Eckenhoff RG. Anesthesia and the old brain. Anesth Analg. 2010;110:421-426.
213. Sanders RD, Manning HJ, Robertson NJ, et al. Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term. Anesthesiology. 2010;113:233-249.
214. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23:876-882. (Pubitemid 36206178)
215. Yon JH, Daniel-Johnson J, Carter LB, et al. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience. 2005;135:815-827.
216. Jevtovic-Todorovic V, Olney JW. PRO: anesthesia-induced developmental neuroapoptosis: status of the evidence. Anesth Analg. 2008;106:1659-1663.
217. Brambrink AM, Evers AS, Avidan MS, et al. Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology. 2010;112:834-841.
218. Culley DJ, Xie Z, Crosby G. General anesthetic-induced neurotoxicity: an emerging problem for the young and old? Curr Opin Anaesthesiol. 2007;20:408-413. (Pubitemid 47415131)
219. DiMaggio C, Sun LS, Kakavouli A, et al. A retrospective cohort study of the association of anesthesia and hernia repair surgery with behavioral and developmental disorders in young children. J Neurosurg Anesthesiol. 2009;21:286-291.
220. Wilder RT, Flick RP, Sprung J, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology. 2009;110:796-804.
221. Gao Y, Liang W, Hu X, et al. Neuroprotection against hypoxicischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway. Stroke. 2010;41:166-172.
222. Liang G, Ward C, Peng J, et al. Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology. 2010;112:1325-1334.
223. Moritz S, Warnat J, Bele S, et al. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2010;22:21-31.
224. Briner A, De Roo M, Dayer A, et al. Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology. 2010;112:546-556.
225. McKernan RM, Whiting PJ. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 1996;19:139-143.
226. Brooks-Kayal AR, Pritchett DB. Developmental changes in human gamma-aminobutyric acidA receptor subunit composition. Ann Neurol. 1993;34:687-693. (Pubitemid 23333241)
227. Mihic SJ, Ye Q, Wick MJ, et al. Sites of alcohol and volatile anaesthetic action on GABA (A) and glycine receptors. Nature. 1997;389:385-389. (Pubitemid 27415220)
228. Piehl E, Foley L, Barron M, et al. The effect of sevoflurane on neuronal degeneration and GABAA subunit composition in a developing rat model of organotypic hippocampal slice cultures. J Neurosurg Anesthesiol. 2010;22:220-229.
229. Dzhala VI, Talos DM, Sdrulla DA, et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med. 2005;11:1205-1213. (Pubitemid 43093668)
230. Edwards DA, Shah HP, Cao W, et al. Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain. Anesthesiology. 2010;112:567-575.
231. Kalenka A, Gross B, Maurer MH, et al. Isoflurane anesthesia elicits protein pattern changes in rat hippocampus. J Neurosurg Anesthesiol. 2010;22:144-154.
232. Stratmann G, Sall JW, May L D V, et al. Beyond anesthetic properties: the effects of isoflurane on brain cell death, neurogenesis, and long-term neurocognitive function. Anesth Analg. 2010;110:431-437.
233. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 1999;30:1969-1973. (Pubitemid 29411843)
234. Endoh M, Maiese K, Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 1994;651:92-100. (Pubitemid 24222853)
235. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
236. Amarenco P, Bogousslavsky J, Callahan A III, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559. (Pubitemid 44202151)
237. Fu JH, Mok V, Lam W, et al. Effects of statins on progression of subclinical brain infarct. Cerebrovasc Dis. 2010;30:51-56.
238. Pan HC, Yang DY, Ou YC, et al. Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury. Neurosurgery. 2010;67:376-388.
239. Capraro JA, Reedy DP, Latchaw JP, et al. Treatment of acute focal cerebral ischemia with propranolol. Stroke. 1984;15:486-491. (Pubitemid 14105962)
240. Latchaw JP, Little JR, Slugg RM, et al. Treatment of acute focal cerebral ischemia and recirculation with d-propranolol. Neurosurgery. 1985;16:18-22. (Pubitemid 15154196)
241. Standefer M, Little JR. Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery. 1986;18:136-140. (Pubitemid 16161273)
242. Kawaguchi M, Utada K, Yoshitani K, et al. Effects of a shortacting [beta]1 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery. J Neurosurg Anesthesiol. 2010;22:230-239.
243. Iwata M, Inoue S, Kawaguchi M, et al. Posttreatment but not pretreatment with selective beta-adrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia. Anesth Analg. 2010;110:1126-1132.
244. Umehara S, Goyagi T, Nishikawa T, et al. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats. Anesth Analg. 2010;110:1133-1137.
245. Yenari MA, Hemmen TM. Therapeutic hypothermia for brain ischemia: where have we come and where do we go? Stroke. 2010;41: S72-S74.
246. Badawi N, Felix JF, Kurinczuk JJ, et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev Med Child Neurol. 2005;47:293-298. (Pubitemid 40662867)
247. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663-670. (Pubitemid 40260887)
248. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353:1574-1584. (Pubitemid 41434636)
249. Rutherford M, Ramenghi LA, Edwards AD, et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial. Lancet Neurol. 2010;9:39-45.
250. Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349-1358.
251. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, et al. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol. 2005;46:450-456. (Pubitemid 41040285)
252. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370:575-579. (Pubitemid 47247853)
253. Abraham VS, Swain JA, Forgash AJ, et al. Ischemic preconditioning protects against paraplegia after transient aortic occlusion in the rat. Ann Thorac Surg. 2000;69:475-479. (Pubitemid 30125577)
254. Toumpoulis IK, Anagnostopoulos CE, Drossos GE, et al. Early ischemic preconditioning without hypotension prevents spinal cord injury caused by descending thoracic aortic occlusion. J Thorac Cardiovasc Surg. 2003;125:1030-1036. (Pubitemid 36644879)
255. Pignataro G, Scorziello A, Di Renzo G, et al. Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy. FEBS J. 2009;276:46-57.
256. Walsh SR, Tang T, Sadat U, et al. Cardioprotection by remote ischaemic preconditioning. Br J Anaesth. 2007;99:611-616. (Pubitemid 351773226)
257. Hu S, Dong HL, Li YZ, et al. Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial. J Neurosurg Anesthesiol. 2010;22:46-52.
258. Sojka P, Stalnacke BM, Bjornstig U, et al. One-year follow-up of patients with mild traumatic brain injury: occurrence of posttraumatic stress-related symptoms at follow-up and serum levels of cortisol, S-100B and neuron-specific enolase in acute phase. Brain Inj. 2006;20:613-620. (Pubitemid 43878693)
259. Nikaido T, Kikuchi S, Yabuki S, et al. Surgical treatment assessment using the Japanese orthopedic association cervical myelopathy evaluation questionnaire in patients with cervical myelopathy: a new outcome measure for cervical myelopathy. Spine. 2009;34:2568-2572.
260. Dong HL, Zhang Y, Su BX, et al. Limb remote ischemic preconditioning protects the spinal cord from ischemia-reperfusion injury: a newly identified nonneuronal but reactive oxygen speciesdependent pathway. Anesthesiology. 2010;112:881-891.
261. Sun XC, Xian XH, Li WB, et al. Activation of p38 MAPK participates in brain ischemic tolerance induced by limb ischemic preconditioning by up-regulating HSP 70. Exp Neurol. 2010;224:347-355.